Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Brammer Bio

Brammer Bio?uq=XnI5dm0O
2006 FOUNDED
M&A STATUS
401-500 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
1 INVESTMENTS
Description

Provider of bio-pharmaceutical development services. The company is engaged in bio pharmaceutical development, manufacturing, and analytical testing services. The company manufactures complex biological drug products for per-clinical studies and early human clinical trials.

Formerly Known As
Florida Biologix
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Cambridge, MA
  • United States

Brammer Bio Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Brammer Bio‘s full profile, request access.

Request full access to PitchBook

Brammer Bio Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 31-Mar-2016 0000000000 Biotechnology 0000000 000000 00.0
To view this company’s complete investment and acquisition history, request access »

Brammer Bio Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Brammer Bio‘s full profile, request access.

Request full access to PitchBook

Brammer Bio Executive Team (3)

Name Title Board
Seat
Contact
Info
Tim Martin Chief Executive Officer
Richard Snyder Ph.D Chief Scientific Officer
Chris Murphy Chief Manufacturing Officer